FDA Drug Application (022532) for BEYAZ by BAYER HLTHCARE

Back to FDA Applications sponsored by BAYER HLTHCARE

Application Number022532
Product Number001
FormTABLET;ORAL
Dosage3MG,N/A;0.02MG,N/A;0.451MG,0.451MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameBEYAZ
Active IngredientDROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM

Active IngredientCount
List of drugs with Active Ingredient DROSPIRENONE12
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient LEVOMEFOLATE CALCIUM3


Back to FDA Applications sponsored by BAYER HLTHCARE